Vaughan H.J. Shalson has been named president...
- Share via
Vaughan H.J. Shalson has been named president and chief executive officer of Cortex Pharmaceuticals Inc., an Irvine developer of neurological drugs. He has also joined the company’s seven-member board of directors.
Shalson was formerly president and chief executive for Bio-Response Inc., a San Francisco Bay Area biotechnology company that was recently acquired by Baxter International. He succeeds Dr. Harold R. Hutchings, who resigned as chief executive of Cortex last April.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
